Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Marit M Melssen"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Increased immune cell infiltration into tumors is associated with improved patient survival and predicts response to immune therapies. Thus, identification of factors that determine the extent of immune infiltration is crucial, so that methods to int
Externí odkaz:
https://doaj.org/article/3095156331ae469a9c305300dd12551f
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Water-in-oil emulsion incomplete Freund’s adjuvant (IFA) has been used as an adjuvant in preventive and therapeutic vaccines since its development. New generation, highly purified modulations of the adjuvant, Montanide incomplete seppic adjuvant (I
Externí odkaz:
https://doaj.org/article/b097e9a4d6bc48179b97981152b135d5
Autor:
Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth M. Gaughan, Craig L. Slingluff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Cancer vaccines require adjuvants to induce effective immune responses; however, there is no consensus on optimal adjuvants. We hypothesized that toll-like receptor (TLR)3 agonist polyICLC or TLR4 agonist lipopolysaccharide (LPS),
Externí odkaz:
https://doaj.org/article/a8026c4ba7c5475c8be9506d9626cbab
Autor:
Victor H. Engelhard, Craig L. Slingluff, Ukpong Eyo, Sjoerd H. van der Burg, Cornelis J.M. Melief, Mark R. Conaway, Melanie R. Rutkowski, Salwador Cyranowski, Amanda M. Briegel, Anthony B. Rodriguez, Katarzyna Stasiak, Robin S. Lindsay, Marit M. Melssen
Movement of cells in anti-CD49b treated tumor slices
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4478c19fb6091a6a24c671662898eeb3
https://doi.org/10.1158/2326-6066.22543948
https://doi.org/10.1158/2326-6066.22543948
Autor:
Victor H. Engelhard, Craig L. Slingluff, Ukpong Eyo, Sjoerd H. van der Burg, Cornelis J.M. Melief, Mark R. Conaway, Melanie R. Rutkowski, Salwador Cyranowski, Amanda M. Briegel, Anthony B. Rodriguez, Katarzyna Stasiak, Robin S. Lindsay, Marit M. Melssen
CD8+ T-cell infiltration and effector activity in tumors are correlated with better overall survival of patients, suggesting that the ability of T cells to enter and remain in contact with tumor cells supports tumor control. CD8+ T cells express the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e1dc70270dc0ac2e683479bff19f1f
https://doi.org/10.1158/2326-6066.c.6550471.v1
https://doi.org/10.1158/2326-6066.c.6550471.v1
Increased immune cell infiltration into tumors is associated with improved patient survival and predicts response to immune therapies. Thus, identification of factors that determine the extent of immune infiltration is crucial, so that methods to int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bf5f0a8d7356ca65f021616f0599ae
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-506604
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-506604
Autor:
Marit M. Melssen, Alexander F. Koeppel, Donna H. Deacon, Gina R. Petroni, Craig L. Slingluff, Alexandra W. Hickman, Max O. Meneveau, Katia Sol-Church, Mark E. Smolkin, Joel Pinczewski, Karlyn Pollack, Stephen D. Turner
Publikováno v:
Cancer Immunology, Immunotherapy. 70:2151-2164
The strength and durability of systemic anti-tumor immune responses induced by cancer vaccines depends on adjuvants to support an immunogenic vaccine site microenvironment (VSME). Adjuvants include water-in-oil emulsions with incomplete Freund's adju
Water-in-oil emulsion incomplete Freund’s adjuvant (IFA) has been used as an adjuvant in preventive and therapeutic vaccines since its development. New generation, highly purified modulations of the adjuvant, Montanide incomplete seppic adjuvant (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bad5c68ef661168bf18afe167bb5d10
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485964
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485964
Autor:
Peter Olofsson-Sahl, Marit M. Melssen, Fei He, Marina Kaisso, Carlos Fernández Moro, Matthias Löhr, Dhifaf Sarhan, Enana Malki, Ahmed Calandigary, Mikael C. I. Karlsson, Rainer Heuchel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmunotherapy for pancreatic cancer (PC) is inefficient due to a highly immune-suppressive tumor microenvironment (TME) orchestrated by myeloid suppressor cells, which limit the infiltration and function of cytotoxic immune cells. We have e
Autor:
Ukpong B. Eyo, Robin S. Lindsay, Anthony B. Rodriguez, Amanda M. Briegel, Sjoerd H. van der Burg, Craig L. Slingluff, Mark R. Conaway, Salwador Cyranowski, Cornelis J. M. Melief, Victor H. Engelhard, Melanie R. Rutkowski, Marit M. Melssen, Katarzyna Stasiak
Publikováno v:
Cancer Immunology Research, 9(5), 583-597. AMER ASSOC CANCER RESEARCH
Cancer Immunol Res
Cancer Immunol Res
CD8+ T-cell infiltration and effector activity in tumors are correlated with better overall survival of patients, suggesting that the ability of T cells to enter and remain in contact with tumor cells supports tumor control. CD8+ T cells express the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86db6690928ddb94b7e903781f15b70
http://hdl.handle.net/1887/3209072
http://hdl.handle.net/1887/3209072